166 related articles for article (PubMed ID: 11262653)
1. Clinical features of human T-lymphotropic virus type 1 uveitis: a long-term follow-up.
Takahashi T; Takase H; Urano T; Sugita S; Miyata K; Miyata N; Mochizuki M
Ocul Immunol Inflamm; 2000 Dec; 8(4):235-41. PubMed ID: 11262653
[TBL] [Abstract][Full Text] [Related]
2. Clinical course of HTLV-I-associated uveitis.
Nakao K; Ohba N; Nakagawa M; Osame M
Jpn J Ophthalmol; 1999; 43(5):404-9. PubMed ID: 10580663
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of human T lymphotropic virus type 1-associated uveitis in Hokkaido, Japan.
Kase S; Namba K; Kitaichi N; Iwata D; Ohno S; Ishida S
Jpn J Ophthalmol; 2013 Jul; 57(4):379-84. PubMed ID: 23608951
[TBL] [Abstract][Full Text] [Related]
4. Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in martinique (French West Indies).
Merle H; Cabre P; Olindo S; Merle S; Smadja D
Am J Ophthalmol; 2002 Aug; 134(2):190-5. PubMed ID: 12140025
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of HTLV-I associated uveitis determined in multicenter collaborative study. Study Group for HTLV-I Associated Ocular Diseases.
Ohba N; Nakao K; Isashiki Y; Kaminagayoshi T; Sonoda S; Yashiki S; Osame M
Jpn J Ophthalmol; 1994; 38(2):168-74. PubMed ID: 7967208
[TBL] [Abstract][Full Text] [Related]
6. Systemic diseases in patients with HTLV-1-associated uveitis.
Nakao K; Abematsu N; Sakamoto T
Br J Ophthalmol; 2018 Mar; 102(3):373-376. PubMed ID: 28689168
[TBL] [Abstract][Full Text] [Related]
7. Pattern-reversal visual evoked potentials in patients with human T-lymphotropic virus type 1 uveitis.
Yukawa E; Urano T; Nakahara M; Miyata K; Matsuura T; Taketani F; Hara Y; Mochizuki M
Curr Eye Res; 2006 Jan; 31(1):37-42. PubMed ID: 16421018
[TBL] [Abstract][Full Text] [Related]
8. Human T-cell Leukemia Virus Type 1 (HTLV-1)-induced Uveitis.
Terada Y; Miyata K; Shoji N; Mochizuki M
Ocul Immunol Inflamm; 2023 Sep; 31(7):1416-1424. PubMed ID: 36803501
[TBL] [Abstract][Full Text] [Related]
9. Human T-lymphotropic virus type I-associated uveitis in patients with Graves' disease treated with methylmercaptoimidazole.
Mizokami T; Okamura K; Kohno T; Sato K; Ikenoue H; Kuroda T; Inokuchi K; Fujishima M
J Clin Endocrinol Metab; 1995 Jun; 80(6):1904-7. PubMed ID: 7775639
[TBL] [Abstract][Full Text] [Related]
10. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy.
Robinson MR; Reed G; Csaky KG; Polis MA; Whitcup SM
Am J Ophthalmol; 2000 Jul; 130(1):49-56. PubMed ID: 11004259
[TBL] [Abstract][Full Text] [Related]
11. Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis. Accumulation of the human T-cell leukemia virus type-1-infected cells and constitutive expression of viral and interleukin-6 messenger ribonucleic acids.
Ono A; Mochizuki M; Yamaguchi K; Miyata N; Watanabe T
Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):676-89. PubMed ID: 9071222
[TBL] [Abstract][Full Text] [Related]
12. Optic neuritis and human T-lymphotropic virus type 1-associated myelopathy: a case report.
Yoshida Y; Saiga T; Takahashi H; Hara A
Ophthalmologica; 1998; 212(1):73-6. PubMed ID: 9438591
[TBL] [Abstract][Full Text] [Related]
13. Human T lymphotropic virus type 1 uveitis after Graves' disease.
Yamaguchi K; Mochizuki M; Watanabe T; Yoshimura K; Shirao M; Araki S; Miyata N; Mori S; Kiyokawa T; Takatsuki K
Br J Ophthalmol; 1994 Mar; 78(3):163-6. PubMed ID: 8148330
[TBL] [Abstract][Full Text] [Related]
14. Provirus load in patients with human T-cell leukemia virus type 1 uveitis correlates with precedent Graves' disease and disease activities.
Ono A; Ikeda E; Mochizuki M; Matsuoka M; Yamaguchi K; Sawada T; Yamane S; Tokudome S; Watanabe T
Jpn J Cancer Res; 1998 Jun; 89(6):608-14. PubMed ID: 9703358
[TBL] [Abstract][Full Text] [Related]
15. Indocyanine green angiography in patients with human T cell-lymphotropic virus type 1 uveitis.
Sakurai T; Yukawa E; Hara Y; Miyata N; Mochizuki M
Graefes Arch Clin Exp Ophthalmol; 2002 Feb; 240(2):101-5. PubMed ID: 11931073
[TBL] [Abstract][Full Text] [Related]
16. Human T-cell lymphotropic virus type 1 infection and ocular manifestations in São Paulo, Brazil.
Yamamoto JH; Segurado AA; Hirata CE; Sampaio MW; Souza EC; Nukui Y; Cliquet M; Saéz-Alquézar A; Olivalves E; Mochizuki M
Arch Ophthalmol; 1999 Apr; 117(4):513-7. PubMed ID: 10206580
[TBL] [Abstract][Full Text] [Related]
17. Complications in Intermediate Uveitis: Prevalence, Time of Onset, and Effects on Vision in Short-Term and Long-Term Follow-Up.
Sancho L; Kramer M; Koriat A; Eiger-Moscovich M; Sharon Y; Amer R
Ocul Immunol Inflamm; 2019; 27(3):447-455. PubMed ID: 29370567
[No Abstract] [Full Text] [Related]
18. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
[TBL] [Abstract][Full Text] [Related]
19. Chikungunya Virus Infection Manifesting as Intermediate Uveitis.
Lin J; Chen RWS; Hazan A; Weiss M
Ocul Immunol Inflamm; 2018; 26(5):680-682. PubMed ID: 28010143
[TBL] [Abstract][Full Text] [Related]
20. [Uveitis in human T-lymphotropic virus type I (HTLV-I) carriers--2. An analysis of clinical features].
Yoshimura K; Shimada N; Shirao M; Mochizuki M; Araki S; Miyata N; Yamaguchi K; Takatsuki K; Watanabe T; Mori S
Nippon Ganka Gakkai Zasshi; 1993 Jun; 97(6):733-40. PubMed ID: 8328342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
